5.010 Apr 2017Very goodDirector, strategy managementCurrent employee, more than 10 yearsBoston, MARecommendCEO approvalBusiness outlookProsDevelopments in international medicine as well as researchConsAdvances are often rolled out to slowly and missing the curveShow more
